Risk factors for selection of the L74I reverse transcriptase mutation in HIV-1 infected patients

被引：0
|
作者：
Marcelin, A. G.
Wirden, M.
Roquebert, B.
Derache, A.
Simon, A.
Ghosn, J.
Dominguez, S.
Katlama, C.
Calvez, V.
机构：
[1] Hop La Pitie Salpetriere, Dept Virol, Paris, France
[2] Hop La Pitie Salpetriere, Dept Internal Med, Paris, France
[3] Univ Paris 06, Paris, France
来源：
ANTIVIRAL THERAPY | 2006年 / 11卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S95 / S95
页数：1
相关论文
共 50 条
  • [21] The N348I Mutation at the Connection Subdomain of HIV-1 Reverse Transcriptase Decreases Binding to Nevirapine
    Schuckmann, Matthew M.
    Marchand, Bruno
    Hachiya, Atsuko
    Kodama, Eiichi N.
    Kirby, Karen A.
    Singh, Kamalendra
    Sarafianos, Stefan G.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (49) : 38700 - 38709
  • [22] Risk factors related to renal disorders in HIV-1 infected patients
    Pinto Neto, Lauro Ferreira Silva
    Costa Braga, Andressa
    Alvarenga Rocha, Juliana
    Rezende Vieira, Nilo Fernando
    Espinosa Miranda, Angelica
    REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2011, 44 (01)
  • [23] The fidelity of HIV-1 reverse transcription: reverse transcriptase variants with altered mutation levels during replication
    Nissley, D. V.
    Shenk, J. L.
    Ambrose, Z.
    Strathern, J. N.
    Sluis-Cremer, N.
    ANTIVIRAL THERAPY, 2008, 13 (04) : A61 - A61
  • [24] The M230L Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutation in HIV-1 Reverse Transcriptase Impairs Enzymatic Function and Viral Replicative Capacity
    Xu, Hong-Tao
    Quan, Yudong
    Schader, Susan M.
    Oliveira, Maureen
    Bar-Magen, Tamara
    Wainberg, Mark A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (06) : 2401 - 2408
  • [25] The fidelity of HIV-1 reverse transcriptase: identification of variants with increased levels of mutation during reverse transcription
    Nissley, D. V.
    Shenk, J. L.
    Ambrose, Z.
    Strathern, J. N.
    Sluis-Cremer, N.
    ANTIVIRAL THERAPY, 2007, 12 : S109 - S109
  • [26] The fidelity of HIV-1 reverse transcriptase: identification of variants with increased levels of mutation during reverse transcription
    Nisslev, D. V.
    Shenk, J. L.
    Ambrose, Z.
    Strathern, J. N.
    Sluis-Cremer, N.
    ANTIVIRAL THERAPY, 2007, 12 (05) : S109 - S109
  • [27] Analysis of HIV-1 reverse transcriptase gene mutations in infected children treated with zidovudine
    Orlandi, P
    Cancrini, C
    Scaccia, S
    Romiti, ML
    Livadiotti, S
    Gattinara, GC
    Angelini, F
    Cox, S
    Rossi, P
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1998, 19 (03) : 230 - 237
  • [28] HIV-1 genotyping of protease and reverse-transcriptase mutation resistances in Kelantan, Malaysia
    Deris, Z. Z.
    Mohamad, S.
    Akram, T. M.
    Ariffin, T. M.
    Mustafa, M.
    Yusof, N. K.
    Chew, C. B.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : S2 - S3
  • [29] RESISTANCE TO DDI AND SENSITIVITY TO AZT INDUCED BY A MUTATION IN HIV-1 REVERSE-TRANSCRIPTASE
    STCLAIR, MH
    MARTIN, JL
    TUDORWILLIAMS, G
    BACH, MC
    VAVRO, CL
    KING, DM
    KELLAM, P
    KEMP, SD
    LARDER, BA
    SCIENCE, 1991, 253 (5027) : 1557 - 1559
  • [30] HIV-1 reverse transcriptase fidelity variants alter levels of mutation during replication
    Nissley, D. V.
    Alptuerk, O.
    Ambrose, Z.
    Eaton, K.
    Strathern, J. N.
    Sluis-Cremer, N.
    ANTIVIRAL THERAPY, 2009, 14 (04) : A24 - A24
12345